Literature DB >> 8940279

The gene for autosomal dominant cerebellar ataxia type II is located in a 5-cM region in 3p12-p13: genetic and physical mapping of the SCA7 locus.

G David1, P Giunti, N Abbas, P Coullin, G Stevanin, W Horta, R Gemmill, J Weissenbach, N Wood, S Cunha, H Drabkin, A E Harding, Y Agid, A Brice.   

Abstract

Two families with autosomal dominant cerebellar ataxia with pigmentary macular dystrophy (ADCA type II) were investigated. Analysis of 23 parent-child couples demonstrated the existence of marked anticipation, greater in paternal than in maternal transmissions, with earlier age at onset and a more rapid clinical course in successive generations. Clinical analysis revealed the presence of a great variability in age at onset, initial symptom, and associated signs, confirming the characteristic clinical heterogeneity of ADCA type II. The gene for ADCA type II previously was mapped to the spinocerebellar ataxia 7 (SCA7) locus on chromosome 3p12-p21.1. Linkage analysis of the two new families of different geographic origin confirmed the characteristic genetic homogeneity of ADCA type II, distinguishing it from ADCA type I. Haplotype analysis permitted refinement of the SCA7 region to the 5-cM interval between markers D3S1312 and D3S1600 on chromosome 3p12-p13. Eighteen sequence-tagged sites were used for the construction of an integrated map of the candidate region, based on a YACs contig. The entire candidate region is contained in a single nonchimeric YAC of 660 kb. The probable involvement of a CAG trinucleotide expansion, suggested by previous studies, should greatly facilitate the identification of the gene for ADCA type II.

Entities:  

Mesh:

Year:  1996        PMID: 8940279      PMCID: PMC1914853     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  27 in total

Review 1.  The olivopontocerebellar atrophies: a review.

Authors:  B W Konigsmark; L P Weiner
Journal:  Medicine (Baltimore)       Date:  1970-05       Impact factor: 1.889

2.  A second-generation YAC contig map of human chromosome 3.

Authors:  R M Gemmill; I Chumakov; P Scott; B Waggoner; P Rigault; J Cypser; Q Chen; J Weissenbach; K Gardiner; H Wang
Journal:  Nature       Date:  1995-09-28       Impact factor: 49.962

3.  A comprehensive genetic map of the human genome based on 5,264 microsatellites.

Authors:  C Dib; S Fauré; C Fizames; D Samson; N Drouot; A Vignal; P Millasseau; S Marc; J Hazan; E Seboun; M Lathrop; G Gyapay; J Morissette; J Weissenbach
Journal:  Nature       Date:  1996-03-14       Impact factor: 49.962

4.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.

Authors:  Y Kawaguchi; T Okamoto; M Taniwaki; M Aizawa; M Inoue; S Katayama; H Kawakami; S Nakamura; M Nishimura; I Akiguchi
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

5.  Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias.

Authors:  Y Trottier; Y Lutz; G Stevanin; G Imbert; D Devys; G Cancel; F Saudou; C Weber; G David; L Tora
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

6.  The gene for autosomal dominant cerebellar ataxia with pigmentary macular dystrophy maps to chromosome 3p12-p21.1.

Authors:  A Benomar; L Krols; G Stevanin; G Cancel; E LeGuern; G David; H Ouhabi; J J Martin; A Dürr; A Zaim
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

7.  Retinal degeneration characterizes a spinocerebellar ataxia mapping to chromosome 3p.

Authors:  L G Gouw; C D Kaplan; J H Haines; K B Digre; S L Rutledge; A Matilla; M Leppert; H Y Zoghbi; L J Ptácek
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

8.  The clinical features and classification of the late onset autosomal dominant cerebellar ataxias. A study of 11 families, including descendants of the 'the Drew family of Walworth'.

Authors:  A E Harding
Journal:  Brain       Date:  1982-03       Impact factor: 13.501

9.  Localization of autosomal dominant cerebellar ataxia associated with retinal degeneration and anticipation to chromosome 3p12-p21.1.

Authors:  M Holmberg; J Johansson; L Forsgren; J Heijbel; O Sandgren; G Holmgren
Journal:  Hum Mol Genet       Date:  1995-08       Impact factor: 6.150

10.  On an autosomal dominant form of retinal-cerebellar degeneration: an autopsy study of five patients in one family.

Authors:  J J Martin; N Van Regemorter; L Krols; J M Brucher; T de Barsy; H Szliwowski; P Evrard; C Ceuterick; M J Tassignon; H Smet-Dieleman
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more
  12 in total

1.  Japanese families with autosomal dominant pure cerebellar ataxia map to chromosome 19p13.1-p13.2 and are strongly associated with mild CAG expansions in the spinocerebellar ataxia type 6 gene in chromosome 19p13.1.

Authors:  K Ishikawa; H Tanaka; M Saito; N Ohkoshi; T Fujita; K Yoshizawa; T Ikeuchi; M Watanabe; A Hayashi; Y Takiyama; M Nishizawa; I Nakano; K Matsubayashi; M Miwa; S Shoji; I Kanazawa; S Tsuji; H Mizusawa
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

2.  Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3.

Authors:  R A Ophoff; J DeYoung; S K Service; M Joosse; N A Caffo; L A Sandkuijl; G M Terwindt; J Haan; A M van den Maagdenberg; J Jen; R W Baloh; M L Barilla-LaBarca; N L Saccone; J P Atkinson; M D Ferrari; N B Freimer; R R Frants
Journal:  Am J Hum Genet       Date:  2001-06-28       Impact factor: 11.025

Review 3.  Histone acetylation, acetyltransferases, and ataxia--alteration of histone acetylation and chromatin dynamics is implicated in the pathogenesis of polyglutamine-expansion disorders.

Authors:  Shaun D McCullough; Patrick A Grant
Journal:  Adv Protein Chem Struct Biol       Date:  2010       Impact factor: 3.507

4.  Spinal cord stimulation for gait impairment in spinocerebellar ataxia 7.

Authors:  Christos Sidiropoulos; Kei Masani; Tiago Mestre; Matija Milosevic; Yu-Yan Poon; Melanie Fallis; Binit B Shah; Suneil K Kalia; Milos R Popovic; Andres M Lozano; Elena Moro
Journal:  J Neurol       Date:  2014-01-05       Impact factor: 4.849

5.  Molecular and clinical study of 18 families with ADCA type II: evidence for genetic heterogeneity and de novo mutation.

Authors:  P Giunti; G Stevanin; P F Worth; G David; A Brice; N W Wood
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

6.  Oxidative Stress in Spinocerebellar Ataxia Type 7 Is Associated with Disease Severity.

Authors:  Y Torres-Ramos; A Montoya-Estrada; B Cisneros; K Tercero-Pérez; G León-Reyes; N Leyva-García; Oscar Hernández-Hernández; Jonathan J Magaña
Journal:  Cerebellum       Date:  2018-10       Impact factor: 3.847

7.  Origin of the spinocerebellar ataxia type 7 gene mutation in Mexican population.

Authors:  J J Magaña; R Gómez; M Maldonado-Rodríguez; L Velázquez-Pérez; Y S Tapia-Guerrero; H Cortés; N Leyva-García; O Hernández-Hernández; B Cisneros
Journal:  Cerebellum       Date:  2013-12       Impact factor: 3.847

8.  Post-zygotic de novo trinucleotide repeat expansion at spinocerebellar ataxia type 7 locus: evidence from an Indian family.

Authors:  Uma Mittal; Sanghamitra Roy; Satish Jain; Achal K Srivastava; Mitali Mukerji
Journal:  J Hum Genet       Date:  2005-03-05       Impact factor: 3.172

9.  Mapping of a new autosomal dominant spinocerebellar ataxia to chromosome 22.

Authors:  L Zu; K P Figueroa; R Grewal; S M Pulst
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

10.  Spinocerebellar ataxias in Brazil--frequencies and modulating effects of related genes.

Authors:  Raphael Machado de Castilhos; Gabriel Vasata Furtado; Tailise Conte Gheno; Paola Schaeffer; Aline Russo; Orlando Barsottini; José Luiz Pedroso; Diego Z Salarini; Fernando Regla Vargas; Maria Angélica de Faria Domingues de Lima; Clécio Godeiro; Luiz Carlos Santana-da-Silva; Maria Betânia Pereira Toralles; Silvana Santos; Hélio van der Linden; Hector Yuri Wanderley; Paula Frassineti Vanconcelos de Medeiros; Eliana Ternes Pereira; Erlane Ribeiro; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2014-02       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.